Constantine S Mitsiades Selected Research

Constantine S Mitsiades Research Topics

Disease

79	Multiple Myeloma 01/2021 - 01/2002
74	Neoplasms (Cancer) 01/2021 - 06/2002
8	Hematologic Neoplasms (Hematological Malignancy) 11/2009 - 03/2004
8	Thyroid Neoplasms (Thyroid Cancer) 12/2007 - 08/2002
6	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2004
5	Retinoblastoma (Glioblastoma, Retinal) 09/2009 - 12/2002
4	Carcinoma (Carcinomatosis) 12/2009 - 09/2006
3	Leukemia 01/2021 - 04/2010
3	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2011
3	Fatigue 01/2012 - 06/2010
3	Medullary Carcinoma 12/2009 - 05/2005
3	Waldenstrom Macroglobulinemia (Macroglobulinemia) 05/2009 - 04/2003
3	Lymphoma (Lymphomas) 12/2005 - 01/2005
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2021 - 10/2006
2	Bone Diseases (Bone Disease) 01/2021 - 01/2012
2	Carcinogenesis 10/2018 - 02/2011
2	Hypoxia (Hypoxemia) 01/2018 - 11/2003
2	Thrombocytopenia (Thrombopenia) 07/2012 - 01/2012
2	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2009 - 08/2004
2	Leukostasis 10/2009 - 08/2004
2	Anaplastic Thyroid Carcinoma 10/2006 - 10/2003
2	Neoplasm Metastasis (Metastasis) 09/2006 - 07/2004
2	Chromosomal Instability (Chromosome Stability) 01/2003 - 07/2002
1	Neuroblastoma 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021
1	Residual Neoplasm 01/2021

Drug/Important Bio-Agent (IBA)

30	Bortezomib (Velcade)FDA Link 01/2021 - 09/2002
19	Proteasome InhibitorsIBA 01/2021 - 06/2002
15	Dexamethasone (Maxidex)FDA LinkGeneric 03/2014 - 03/2002
14	Lenalidomide (CC 5013)FDA Link 01/2021 - 06/2004
13	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2003
13	Thalidomide (Thalomid)FDA Link 01/2014 - 06/2002
12	Pharmaceutical PreparationsIBA 01/2021 - 05/2004
11	NF-kappa B (NF-kB)IBA 04/2010 - 06/2002
10	Biological ProductsIBA 01/2021 - 01/2002
7	Insulin-Like Growth Factor I (IGF-1)IBA 10/2006 - 08/2002
6	LigandsIBA 01/2018 - 03/2002
6	Immunomodulating AgentsIBA 06/2015 - 04/2009
6	Vorinostat FDA Link 07/2013 - 04/2003
6	Histone Deacetylase InhibitorsIBA 07/2013 - 04/2003
6	Antineoplastic Agents (Antineoplastics)IBA 11/2012 - 02/2006
6	Phosphotransferases (Kinase)IBA 01/2011 - 03/2004
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2003
5	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2017 - 10/2002
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2012 - 03/2002
5	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2012 - 03/2003
4	Transcription Factors (Transcription Factor)IBA 01/2016 - 06/2002
4	CytokinesIBA 10/2013 - 07/2002
4	GlucocorticoidsIBA 07/2012 - 01/2005
4	tanespimycin (17AAG)IBA 02/2011 - 02/2006
4	Neutralizing AntibodiesIBA 10/2009 - 03/2004
4	AndrogensIBA 09/2006 - 03/2004
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021 - 06/2006
3	Histone Deacetylases (Histone Deacetylase)IBA 07/2013 - 01/2004
3	Melphalan (Alkeran)FDA LinkGeneric 07/2012 - 03/2003
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2011 - 10/2002
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2009 - 05/2005
3	Complementary DNA (cDNA)IBA 10/2009 - 05/2005
3	Death Domain ReceptorsIBA 06/2006 - 01/2005
3	Caspase 8 (Caspase-8)IBA 06/2006 - 01/2005
3	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 06/2006 - 11/2003
3	geldanamycinIBA 02/2006 - 04/2003
3	Interleukin-6 (Interleukin 6)IBA 08/2005 - 07/2002
3	Insulin-Like PeptidesIBA 03/2004 - 07/2002
2	AntibodiesIBA 01/2022 - 08/2005
2	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 09/2011
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2021
2	PanobinostatIBA 01/2021 - 07/2013
2	Hormones (Hormone)IBA 01/2021 - 11/2012
2	RNA (Ribonucleic Acid)IBA 01/2021 - 03/2007
2	ixazomibIBA 01/2021 - 10/2018
2	Histones (Histone)IBA 07/2014 - 11/2009
2	Estrogen ReceptorsIBA 07/2014 - 02/2006
2	LuciferasesIBA 10/2013 - 04/2010
2	Caspase 3 (Caspase-3)IBA 10/2013 - 12/2009
2	Peptides (Polypeptides)IBA 09/2012 - 03/2004
2	Diphosphonates (Bisphosphonates)IBA 01/2012 - 09/2006
2	Zoledronic Acid (Zometa)FDA Link 01/2012 - 09/2006
2	DepsipeptidesIBA 06/2010 - 07/2008
2	plitidepsin (aplidine)IBA 06/2010 - 07/2008
2	Imatinib Mesylate (Gleevec)FDA Link 04/2010 - 10/2003
2	Alkylating AgentsIBA 07/2008 - 07/2007
2	CaspasesIBA 10/2007 - 05/2005
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 09/2006 - 07/2004
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2005 - 03/2004
2	Monoclonal AntibodiesIBA 06/2005 - 01/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2004 - 11/2003
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2003 - 07/2002
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2022
1	Androgen Antagonists (Antiandrogens)IBA 01/2021
1	Hepatitis B e AntigensIBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Cyclin-Dependent Kinase 9IBA 01/2021
1	peptidase 7IBA 01/2021
1	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2021

Therapy/Procedure

38	Therapeutics 01/2022 - 04/2003
12	Drug Therapy (Chemotherapy) 01/2021 - 03/2002
4	Immunotherapy 01/2022 - 10/2013
2	Stem Cell Transplantation 06/2015 - 02/2009